Breaking News25 April

Sofosbuvir/daclatasvir combination effective treatment for difficult-to-treat hep C patients

European Association for the Study of the Liver

DCV, SOF & RBV comb. effective/tolerated in HCV with adv, cirrhosis / post-transplant recurrence

European Association for the Study of the Liver

Sofosbuvir + peginterferon/ribavirin demonstrates virologic response rates in G3 hep C patients

European Association for the Study of the Liver
24 April